
### [NCIT:C6432](http://purl.obolibrary.org/obo/NCIT_C6432)
**Label:** Multiple Endocrine Neoplasia

**Subclasses:** [NCIT:C3225](http://purl.obolibrary.org/obo/NCIT_C3225) (Multiple Endocrine Neoplasia Type 1), [NCIT:C3227](http://purl.obolibrary.org/obo/NCIT_C3227) (Multiple Endocrine Neoplasia Type 2B), [NCIT:C3226](http://purl.obolibrary.org/obo/NCIT_C3226) (Multiple Endocrine Neoplasia Type 2A), [NCIT:C123329](http://purl.obolibrary.org/obo/NCIT_C123329) (Multiple Endocrine Neoplasia Type 2), 

**Class expressions from DL-Learner:**

- [NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion) 56.25%
- [CL:0002258](http://purl.obolibrary.org/obo/CL_0002258) (thyroid follicular cell) 56.25%
- [CL:0002257](http://purl.obolibrary.org/obo/CL_0002257) (epithelial cell of thyroid gland) 56.25%
- Thing 52.26%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39250](http://purl.obolibrary.org/obo/NCIT_C39250) (Mucosal Healing Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39247](http://purl.obolibrary.org/obo/NCIT_C39247) (Telomere Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39246](http://purl.obolibrary.org/obo/NCIT_C39246) (T Cell Receptor Signaling Pathway BioCarta))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39236](http://purl.obolibrary.org/obo/NCIT_C39236) (Sprouty Regulation of Tyrosine Kinase Signaling Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39217](http://purl.obolibrary.org/obo/NCIT_C39217) (Ras Signaling Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39208](http://purl.obolibrary.org/obo/NCIT_C39208) (Rac1 Cell Motility Signaling Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39197](http://purl.obolibrary.org/obo/NCIT_C39197) (PPAR-alpha Gene Regulation Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39194](http://purl.obolibrary.org/obo/NCIT_C39194) (Phospholipase C Signaling Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39184](http://purl.obolibrary.org/obo/NCIT_C39184) (PDGF Signaling Pathway))) 41.61%
- [NCIT:C48615](http://purl.obolibrary.org/obo/NCIT_C48615) (Lesion by Focality) and (not ([NCIT:C39168](http://purl.obolibrary.org/obo/NCIT_C39168) (NO2-Dependent IL12 Pathway))) 41.61%


